|
TRIM39 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.05149999818366E-08 |
| Normal-vs-Stage2 |
4.41610004120463E-09 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
3.31509999995649E-06 |
| Stage1-vs-Stage2 |
2.194600E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
9.627800E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
1.558790E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.200030E-01 |
| Normal-vs-Asian |
3.49440032465509E-10 |
| Caucasian-vs-AfricanAmerican |
9.301800E-02 |
| Caucasian-vs-Asian |
1.722260E-03 |
| AfricanAmerican-vs-Asian |
5.578800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.38690001097552E-09 |
| Normal-vs-Female |
2.74259503996177E-11 |
| Male-vs-Female |
8.762800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.13100000001631E-06 |
| Normal-vs-Extreme_Weight |
4.95169999448208E-08 |
| Normal-vs-Obese |
4.44170000002408E-07 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
8.094200E-01 |
| Normal_Weight-vs-Obese |
2.505600E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
5.032400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.87869999557222E-08 |
| Normal-vs-Age(41-60Yrs) |
4.12839999996972E-06 |
| Normal-vs-Age(61-80Yrs) |
1.18209886323939E-11 |
| Normal-vs-Age(81-100Yrs) |
1.11660000023939E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.321000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.811800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.784000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.268600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.267800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.759000E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
9.676600E-01 |
| Normal-vs-Grade 3 |
8.384800E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
7.083800E-01 |
| Grade 2-vs-Grade 4 |
9.676600E-01 |
| Grade 3-vs-Grade 4 |
8.384800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.77302617032637E-12 |
| Normal-vs-N1 |
9.048000E-04 |
| N0-vs-N1 |
9.669000E-01 |
|
|
